EUVIMEDEUVIMED entdecken
Crossref

Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department

Patrick J Allen iD, Kendra E Johanson, Kelly R Reveles, Luke A Neff, Ashley E Lock iD

Annals of Pharmacotherapy · 2023

DOI: 10.1177/10600280231163192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2023. Verfasst von Patrick J Allen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy and Pharmacy Services, University Health, Antonio, TX, USA. Hauptthemen laut MEDLINE: Haloperidol, Antipsychotic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute agitation accounts for up to 2.6% of visits to the emergency department (ED). To date, a standard of care for the management of acute agitation has not been established. Few studies have evaluated antipsychotic and benzodiazepine combinations.

Objective

The purpose of this study was to evaluate effectiveness and safety of combination therapy for acute agitation with intramuscular (IM) droperidol and midazolam (D+M) compared with IM haloperidol and lorazepam (H+L) in patients in the ED.

Methods

This was a single-center, retrospective medical record review of patients presenting to a large, academic ED with acute agitation from July 2020 through October 2021. The primary outcome was percentage of patients requiring additional agitation medication within 60 minutes of combination administration. Secondary outcomes included average time to repeat dose administration and average number of repeat doses required before ED discharge.

Results

A total of 306 patients were included for analysis: 102 in the D+M group and 204 in the H+L group. Repeat dose within 60 minutes occurred in 7 (6.9%) and 28 (13.8%) patients in the D+M and H+L groups, respectively ( P = 0.065). A total of 28.4% of D+M patients and 30.9% of H+L patients required any repeat dose during their ED visit. Time to repeat dose was 12 and 24 minutes in the D+M and H+L, respectively ( P = 0.22). The adverse event rate was 2.9% in each group. Conclusion and Relevance: IM D+M resulted in a lower rate of repeat doses of acute agitation medication compared with IM H+L, though this was not statistically significant. Both therapies were safe, and the adverse event rate was low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaloperidolAntipsychotic AgentsHumansMidazolamLorazepamDroperidolRetrospective StudiesPsychomotor AgitationInjections, IntramuscularEmergency Service, Hospital

Stichwörter der Autor:innen

acute agitationantipsychoticsbenzodiazepinesdroperidol and midazolamemergency departmenthaloperidol and lorazepam

Substanzen

HaloperidolMidazolamLorazepamDroperidolAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Pharmacotherapy and Pharmacy Services, University Health, Antonio, TX, USA.
  • Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA.
  • Pharmacotherapy Education & Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
  • Department of Emergency Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

ORCID-Profile: Patrick J Allen, Ashley E Lock

Zitieren

APA

Allen, P. J., Johanson, K. E., Reveles, K. R., Neff, L. A., & Lock, A. E. (2023). Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280231163192

Vancouver

Allen PJ, Johanson KE, Reveles KR, Neff LA, Lock AE. Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department. Annals of Pharmacotherapy. 2023. doi:10.1177/10600280231163192

BibTeX
@article{Allen2023,
  author = {Allen, Patrick J and Johanson, Kendra E and Reveles, Kelly R and Neff, Luke A and Lock, Ashley E},
  title = {Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department},
  journal = {Annals of Pharmacotherapy},
  year = {2023},
  doi = {10.1177/10600280231163192}
}
Kostenlos starten →